Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-25-121130
Filing Date
2025-12-15
Accepted
2025-12-15 16:12:19
Documents
1
Effectiveness Date
2025-12-15

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2533416d7_s8pos.htm S-8 POS 31294
  Complete submission text file 0001104659-25-121130.txt   32558
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-202677 | Film No.: 251571707
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)